|
Guide |
|
Abstract
|
Received: 30 November 2020
|
|
Fund: |
|
|
|
[1] |
Stanescu-Segall D, Balta F, Jackson TL. Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature. Surv Ophthalmol, 2016, 61(1): 18-32. DOI: 10.1016/j.survophthal.2015.04.004.
|
[2] |
Quiroz-Mendoza JL, Valera-Cornejo DA, García-Roa M, et al. Different approaches in the management of macular hemorrhage: Case reports and a literature review. Medwave, 2020, 20(2): e7831. DOI: 10.5867/medwave.2020.02.7831.
|
[3] |
Kimura S, Morizane Y, Matoba R, et al. Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: Effectiveness and safety of subretinal tissue plasminogen activator. Jpn J Ophthalmol, 2017, 61(6): 472-478. DOI: 10.1007/s10384-017-0530-0.
|
[4] |
Durukan AH, Kerimoglu H, Erdurman C, et al. Long-term results of Nd∶YAG laser treatment for premacular subhyaloid haemorrhage owing to Valsalva retinopathy. Eye (Lond), 2008, 22(2): 214-218. DOI: 10.1038/sj.eye.6702574.
|
[5] |
Chang YS, Kim JH, Kim JW, et al. Development of submacular hemorrhage in neovascular age-related macular degeneration: Influence on visual prognosis in a clinical setting. Korean J Ophthalmol, 2018, 32(5): 361-368. DOI: 10.3341/kjo.2017.0095.
|
[6] |
Hattenbach LO, Klais C, Koch FH, et al. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditionsOphthalmology, 2001,108(8): 1485-1492. DOI: 10.1016/s0161- 6420(01)00648-0.
|
[7] |
Heriot WJ. Intravitreal gas and tPA: An outpatient procedure for subretinal haemorrhage. In: Vail Vitrectomy Meeting, 1996, Vail, Colorado.
|
[8] |
Buschini E, Iannetta D, Lesnik Oberstein SY, et al. Subretinal versus intravitreal injection of recombinant tissue plasminogen activator in post-traumatic submacular haemorrhages. Acta Ophthalmol, 2016, 94(3): 307-309. DOI: 10.1111/aos.12816.
|
[9] |
张杰, 徐鑫彦, 高荣玉, 等. 组织型纤溶酶原激活剂、雷珠单 抗联合C3F8治疗息肉样脉络膜血管病变并发早期黄斑下出 血的疗效观察. 中华眼底病杂志, 2018, 34(5): 448-452. DOI: 10.3760/cma.j.issn.1005-1015.2018.05.007.
|
[10] |
Kitagawa Y, Shimada H, Mori R, et al. Intravitreal tissue plasminogen activator, ranibizumab, and gas injection for submacular hemorrhage in polypoidal choroidal vasculopathy. Ophthalmology, 2016, 123(6): 1278-1286. DOI: 10.1016/ j.ophtha.2016.01.035.
|
[11] |
Inoue M, Shiraga F, Shirakata Y, et al. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm. Graefes Arch Clin Exp Ophthalmol, 2015, 253(10): 1663-1669. DOI: 10.1007/s00417-014-2861-6.
|
[12] |
Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina, 1991, 11(2): 250-258. DOI: 10.1097/00006982- 199111020-00011.
|
[13] |
Chen CY, Hooper C, Chiu D, et al. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina, 2007, 27(3): 321-328. DOI: 10.1097/01.iae.0000237586.48231.75.
|
[14] |
Treumer F, Roider J, Hillenkamp J. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage. Br J Ophthalmol, 2012, 96(5): 708-713. DOI: 10.1136/bjophthalmol-2011-300655.
|
[15] |
Sagara N, Kawaji T, Koshiyama Y, et al. Macular hole formation after macular haemorrhage associated with rupture of retinal arterial macroaneurysm. Br J Ophthalmol, 2009, 93(10): 1337- 1340. DOI: 10.1136/bjo.2008.149195.
|
[16] |
Lewis H, Resnick SC, Flannery JG, et al. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol, 1991, 111(2): 197-204. DOI: 10.1016/s0002- 9394(14)72259-7.
|
[17] |
Humayun M, Lewis H, Flynn HW Jr, et al. Management of submacular hemorrhage associated with retinal arterial macroaneurysms. Am J Ophthalmol, 1998, 126(3): 358-361. DOI: 10.1016/s0002-9394(98)00090-7.
|
[18] |
Toth CA, Morse LS, Hjelmeland LM, et al. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol, 1991, 109(5): 723-729. DOI: 10.1001/ archopht.1991.01080050139046.
|
[1] |
. [J]. Chinese Journal of Optometry Ophthalmology and Visual science, 2023, 25(8): 0-. |
|
|
|